Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Alcon Inc.

ALC

Valuace

Růst

Zdraví

Cena

$ 74.07

--0.67 (-0.84%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

36.6B

Obrat

10B

Zisk

Aktiva

31B

Dluh

ROE

ROA

Cena 1R

72-99

⌀ Cena

83.09

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

24-02-2026

Poslední dividenda

13-05-2025

Profil

Společnost Alcon Inc., zabývající se péčí o zrak, provádí výzkum, vývoj, výrobu, distribuci a prodej přípravků pro péči o zrak pro odborníky v oblasti péče o zrak a jejich pacienty po celém světě. Surgical segment společnosti nabízí vybavení, přístrojové vybavení a diagnostiku, nitrooční čočky (IOL) a další implantabilní prostředky; a spotřební materiál, včetně viskoelastiky, chirurgických řešení, řezných nástrojů, chirurgických vlastních balení a dalších produktů pro použití při chirurgických zákrocích. Mezi jeho produkty katarakty patří systém centurionového vidění, LenSx femtosecond laser, LuxOR chirurgický oční mikroskop, NGENUITY 3D vizualizační systém a ORA systém pro vnitrooperační měření; vlastní pak chirurgické zákroky balíčky; vitreoretické produkty sestávající ze systémů konstelačního vidění, zákrokových balíčků, laserů a ručních mikrochirurgických nástrojů a grieshaber a MIVS nástroje, jakož i nůžky, vidlice a mikronástroje, vitreózní taponáty lékařské kvality a refrakční sondy Hypervit vitomy; produkty, včetně laserů WaveLight a Contoura Vision používaných pro léčbu LASIK; filtrační zařízení pro glaukom EX-PRESS a implantabilní produkty, včetně produktů AcrySof IQ IOL, zahrnují monofokální IOL a pokročilé technologie IOL pod značkami PanOptix a ReSTOR pro korekci presbyopie a astigmatismu v době operace katarakty. Jeho segment Vision Care poskytuje denní jednorázové, opakovaně použitelné kontaktní čočky a čočky zvyšující barvu, oční zdravotnické produkty, jako jsou suché oko, glaukom, péče o kontaktní čočky a oční alergie, a oční vitamíny a zmírňující zarudnutí pod značkami TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS a Vitalux. Společnost byla dříve známá jako Alcon Universal S.A. a v prosinci 2001 změnila název na Alcon Inc. Společnost Alcon Inc. byla založena v roce 1945 a sídlí ve švýcarské Ženevě.

Sektor

Healthcare

Odvětví

Medical - Instruments & Supplies

Počet zaměstnanců

25599

Založení

2019-04-09

Adresa

Chemin de Blandonnet 8

CEO

David J. Endicott

Web

www.alcon.com

Podobné společnosti

RMD

ResMed Inc.

$ 248.57

- $ 2.92

IQV

IQVIA Holdings Inc.

$ 211.92

+ $ 1.46

Agilent Technologies, Inc.

$ 146.16

- $ 0.58

GEHC

GE HealthCare Technologies Inc.

$ 72.93

- $ 0.12

HUM

Humana Inc.

$ 243.67

- $ 8.38

BDX

Becton, Dickinson and Company

$ 177.84

- $ 0.07

MTD

Mettler-Toledo International Inc.

$ 1425.49

- $ 13.87

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliardách (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total Revenues	10.40	10.40	9.91	9.46	8.72	8.29	6.83	7.51	7.28	6.79	6.60
Cost of Revenues	4.70	4.66	4.40	4.21	3.97	3.64	3.89	3.85	4.08	3.59	3.49
Gross Profit	5.70	5.75	5.51	5.25	4.75	4.65	2.94	3.66	3.19	3.20	3.11

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	2.72	2.61	2.60	2.47	2.50	2.45	2.50	2.46	2.48	2.33
Cost of Revenues	1.25	1.16	1.21	1.09	1.12	1.08	1.12	1.08	1.13	1.04
Gross Profit	1.47	1.46	1.39	1.38	1.39	1.37	1.37	1.38	1.35	1.29

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
R&D Expenses	0.00	0.00	0.00	0.86	0.70	0.84	0.67	0.66	0.59	0.58	0.50
Selling General & Admin Expenses	0.00	0.00	0.00	3.21	3.07	3.08	2.69	2.85	2.80	2.60	2.53
Depreciation & Amortization	0.59	1.19	1.23	1.22	1.05	1.18	1.63	1.43	1.64	1.31	1.29
Total Operating Expenses	4.34	4.39	4.10	4.21	4.08	4.07	3.42	3.85	3.44	3.28	3.10
Operating Income	1.36	1.36	1.41	1.04	0.67	0.58	-0.51	-0.20	-0.25	-0.08	0.01

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.20
Selling General & Admin Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.84	0.80
Depreciation & Amortization	0.26	0.33	0.00	0.00	0.00	0.29	0.31	0.29	0.33	0.30
Total Operating Expenses	1.16	1.13	1.14	0.92	0.99	1.04	1.06	1.01	0.90	1.00
Operating Income	0.31	0.33	0.25	0.47	0.40	0.33	0.32	0.37	0.45	0.29

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Interest Income	0.00	0.00	0.08	0.03	0.02	0.00	0.01	0.01	0.00	0.00	0.00
Interest Expense	0.15	0.00	0.19	0.19	0.13	0.12	0.12	0.11	0.13	0.03	0.03
Other Expense	-0.20	-0.20	-0.16	-0.21	-0.21	-0.16	-0.12	-0.13	-0.05	-0.02	-0.08
IBT	1.16	1.16	1.26	0.83	0.46	0.42	-0.64	-0.33	-0.41	-0.13	-0.11
Income Tax Expense	0.18	0.18	0.24	-0.14	0.13	0.04	-0.10	0.32	-0.10	-0.38	0.06
Net Income	0.98	0.98	1.02	0.97	0.34	0.38	-0.53	-0.66	-0.32	0.26	-0.17

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.00	0.00	0.00	0.00	0.04	0.01	0.01	0.01	0.00	0.00
Interest Expense	0.00	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Other Expense	-0.05	-0.05	-0.05	-0.05	-0.05	-0.04	-0.04	-0.03	-0.04	-0.06
IBT	0.26	0.28	0.20	0.41	0.35	0.29	0.28	0.34	0.18	0.24
Income Tax Expense	0.05	0.05	0.02	0.06	0.07	0.03	0.06	0.09	-0.27	0.03
Net Income	0.22	0.24	0.18	0.35	0.28	0.26	0.22	0.25	0.43	0.20

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
EPS	$0.00	$0.00	$0.00	$1.98	$0.68	$0.77	$-1.09	$-1.34	$-0.64	$0.52	$-0.35
EPS Diluted	$0.00	$0.00	$0.00	$1.96	$0.68	$0.76	$-1.09	$-1.34	$-0.64	$0.52	$-0.35
Shares Outstanding	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.49
Diluted Shares Outstanding	0.49	0.50	0.50	0.50	0.49	0.49	0.49	0.49	0.49	0.49	0.49

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.91	$0.40
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.91	$0.40
Shares Outstanding	0.49	0.49	0.50	0.50	0.49	0.49	0.49	0.49	0.49	0.49
Diluted Shares Outstanding	0.49	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.49	0.50

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017
Cash And Equivalents	1.37	1.68	1.09	0.98	1.58	1.56	0.82	0.50	0.17
Short Term Investments	0.00	0.15	0.01	-0.18	0.00	0.01	0.03	0.00	0.00
Total Cash & ST Investments	1.37	1.83	1.10	0.98	1.58	1.56	0.86	0.50	0.17
Accounts Receivable	2.06	2.08	1.98	1.69	1.81	1.38	1.79	1.65	1.76
Inventory	2.33	2.27	2.32	2.11	1.90	1.64	1.51	1.44	1.30
Other Current Assets	0.22	0.13	0.24	0.42	0.10	0.40	0.09	0.05	0.06
Total Current Assets	5.98	6.31	5.65	5.19	5.39	4.99	4.24	3.63	3.29

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	1.50	1.41	1.41	1.68	1.57	1.37	1.14	1.09	1.05	0.66
Short Term Investments	0.00	0.00	0.00	0.15	0.42	0.00	0.00	0.01	0.00	0.00
Total Cash & ST Investments	1.50	1.41	1.41	1.83	1.99	1.37	1.14	1.10	1.05	0.66
Accounts Receivable	1.94	2.02	1.86	2.08	1.74	2.06	2.01	1.89	1.96	2.03
Inventory	2.43	2.39	2.34	2.27	2.38	2.33	2.32	2.32	2.32	2.27
Other Current Assets	0.46	0.49	0.46	0.13	0.21	0.22	0.23	0.34	0.21	0.23
Total Current Assets	6.33	6.31	6.07	6.31	6.32	5.99	5.70	5.65	5.54	5.20

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017
Net Property, Plant & Equipment	4.68	4.84	4.72	4.42	4.08	3.78	3.44	2.88	2.56
Goodwill	8.92	8.95	8.93	8.97	8.91	8.91	8.91	8.90	8.90
Intangible Assets	8.76	8.59	9.06	9.69	8.77	9.10	10.23	10.68	11.54
Long-Term Investments	0.53	0.75	0.32	0.29	0.05	0.22	0.06	0.05	0.05
Other Long-Term Assets	0.37	0.50	0.50	0.24	0.40	0.21	0.43	0.49	0.53
Total Long-Term Assets	23.72	24.04	23.97	24.02	22.61	22.61	23.42	23.67	24.10
Total Assets	29.70	30.35	29.61	29.21	28.00	27.60	27.66	27.30	27.39

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	5.14	5.08	4.90	4.84	4.84	4.68	4.68	4.72	4.48	4.47
Goodwill	9.25	9.18	9.18	8.95	8.95	8.93	8.93	8.92	8.92	8.96
Intangible Assets	9.16	9.20	9.38	8.59	8.71	8.76	8.92	9.06	9.21	9.37
Long-Term Investments	0.74	0.76	0.50	0.75	0.36	0.41	0.39	0.27	0.32	0.44
Other Long-Term Assets	0.40	0.40	0.55	0.50	1.19	0.50	0.50	0.53	0.45	0.34
Total Long-Term Assets	25.16	25.08	24.94	24.04	24.04	23.73	23.86	23.96	23.80	23.99
Total Assets	31.49	31.39	31.01	30.35	30.36	29.72	29.57	29.60	29.35	29.18

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017
Accounts Payable	0.87	0.77	0.81	0.86	0.90	0.88	0.83	0.66	0.62
Short-Term Debt	0.21	0.17	0.22	0.17	0.17	0.23	0.31	1.74	0.07
Other Current Liabilities	1.08	1.10	1.34	1.66	1.29	1.04	1.06	1.02	0.96
Current Liabilities	2.34	2.28	2.48	2.78	2.47	2.26	2.30	3.51	1.78

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.89	0.90	0.84	0.77	0.85	0.87	0.82	0.81	0.89	0.90
Short-Term Debt	0.65	0.15	0.17	0.17	0.19	0.21	0.19	0.22	0.20	0.17
Other Current Liabilities	1.44	1.17	1.11	1.10	1.42	1.08	0.98	1.34	1.13	1.02
Current Liabilities	2.99	2.42	2.25	2.28	2.46	2.34	2.27	2.48	2.50	2.40

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017
Long-Term Debt	4.55	4.97	4.93	4.90	4.31	4.26	3.50	1.83	0.08
Capital Leases	0.33	0.50	0.41	0.43	0.41	0.39	0.34	0.00	0.08
Def. Tax Liability	0.79	0.72	0.80	1.06	1.03	1.20	1.39	1.53	1.64
Total Liabilities	8.77	8.79	8.99	9.53	8.74	8.78	8.35	7.79	4.36

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	4.59	5.10	5.02	4.97	4.93	4.88	4.88	4.93	4.90	4.93
Capital Leases	0.00	0.52	0.50	0.50	0.43	0.40	0.40	0.33	0.34	0.35
Def. Tax Liability	0.91	0.86	0.89	0.72	0.00	0.79	0.82	0.80	1.08	1.10
Total Liabilities	9.43	9.26	8.99	8.79	8.97	8.78	8.74	8.99	9.21	9.26

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.00
Retained Earnings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.94
Comprehensive Income	20.91	21.53	20.60	19.66	19.24	18.80	19.28	19.50	0.09
Total Common Equity	20.93	21.55	20.62	19.68	19.26	18.82	19.30	19.52	23.03

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Retained Earnings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Comprehensive Income	22.04	22.09	21.98	21.53	21.37	20.91	20.81	20.60	20.12	19.90
Total Common Equity	22.06	22.11	22.00	21.55	21.39	20.93	20.83	20.62	20.14	19.92

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017
Total Debt		5.09	5.14	5.14	5.07	4.48	4.50	3.80	3.57	0.15
Book Value		20.93	21.55	20.62	19.68	19.26	18.82	19.30	19.52	23.03

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.00	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book Value		22.06	22.11	22.00	21.55	21.39	20.93	20.83	20.62	20.14	19.92

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	1.12	0.98	1.02	1.04	0.34	0.38	-0.53	-0.66	-0.23	0.26	-0.17
Depreciation & Amortization	1.24	1.19	1.23	1.30	1.12	1.22	1.63	1.43	1.64	1.31	1.29
Stock-Based Compensation	0.16	0.00	0.15	0.14	0.14	0.14	0.11	0.08	-0.23	0.05	-0.10
Change Working Capital	-0.11	-0.30	-0.19	-0.43	-0.53	-0.31	-0.05	-0.05	0.08	0.04	0.18
Change In Accounts Receivable	-0.09	0.00	-0.06	-0.12	-0.16	-0.20	0.04	-0.12	0.05	-0.05	-0.15
Change In Accounts Payable	-0.02	0.00	-0.02	-0.05	-0.05	0.06	-0.02	0.08	0.04	0.05	0.08
Change In Inventories	-0.14	0.00	-0.05	-0.29	-0.22	-0.33	-0.16	-0.11	-0.15	-0.09	-0.06
Other Non-cash Items	1.58	0.40	-0.37	-0.43	0.02	-0.12	-0.23	-0.21	-0.04	0.00	-0.11
Cash from Operations	1.87	0.00	0.00	1.48	1.22	1.35	0.82	0.92	1.14	1.22	1.25

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	0.22	0.24	0.18	0.35	0.27	0.27	0.22	0.25	0.45	0.20
Depreciation & Amortization	0.19	0.33	0.22	0.31	0.30	0.32	0.31	0.30	0.33	0.30
Stock-Based Compensation	-0.12	0.00	0.04	0.04	0.00	0.00	0.03	0.04	0.05	0.04
Change Working Capital	0.08	0.08	-0.14	-0.32	-0.04	0.16	-0.03	-0.32	0.01	0.23
Change In Accounts Receivable	0.09	0.08	-0.11	-0.06	-0.07	0.14	0.00	-0.09	0.00	0.03
Change In Accounts Payable	0.00	-0.02	0.00	0.00	-0.05	-0.04	0.00	0.03	-0.05	-0.04
Change In Inventories	0.18	-0.07	-0.04	-0.07	0.04	-0.02	0.00	-0.03	0.01	-0.08
Other Non-cash Items	0.29	0.05	0.22	0.01	-0.07	-0.02	-0.07	-0.01	0.40	0.46
Cash from Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.50

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Capital Expenditure	-0.78	-0.54	-0.47	-0.66	-0.75	-1.18	-0.57	-0.68	-0.71	-0.50	-0.51
Acquisitions	0.03	-0.69	-0.22	0.00	-0.67	0.48	0.00	-0.28	-0.24	-0.07	-0.30
Investments	-0.11	0.00	-0.28	-0.23	-0.05	-0.02	-0.01	-0.06	-0.06	-0.11	0.00
Sales of Investment	0.01	0.00	0.01	0.00	0.08	0.00	0.00	0.01	0.01	0.00	-0.06
Other Investing Activities	-0.14	0.00	0.00	-0.20	-0.49	-0.48	0.01	0.00	0.00	-0.08	-0.09
Cash from Investing	-0.89	0.00	0.00	-1.09	-1.87	-1.20	-0.57	-1.01	-1.00	-0.68	-0.84

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.17	-0.18	-0.10	-0.11	-0.23	-0.17	-0.09	-0.14	-0.37	-0.14
Acquisitions	0.00	-0.12	0.00	-0.57	0.00	-0.06	0.00	0.00	0.00	0.03
Investments	0.00	0.00	0.00	0.00	-0.09	-0.09	-0.02	-0.08	-0.02	0.00
Sales of Investment	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
Other Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.03
Cash from Investing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.40	-0.14

Cash Flow From Financing Activities	TTM	2025	2023	2022	2021	2020	2019	2018	2017	2016
Debt Repaid	-0.08	0.00	-0.01	-2.34	-0.07	-0.07	-2.06	0.00	0.00	0.00
Debt Issued	0.06	5.14	0.07	2.93	0.06	0.76	2.30	3.42	0.15	0.00
Issuance of Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Stock	-0.04	-0.72	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividends Paid	-0.13	0.00	-0.12	-0.10	-0.05	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	-0.09	0.00	-0.04	2.43	0.00	0.54	2.72	-0.08	-0.54	-0.44
Cash from Financing	-0.29	0.00	-0.21	-0.01	-0.12	0.47	0.66	-0.08	-0.54	-0.44

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.03
Debt Issued	5.23	-0.02	0.06	0.06	0.01	0.04	0.00	-0.06	0.06	0.03
Issuance of Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Stock	-0.31	-0.25	-0.13	-0.03	0.00	0.00	-0.01	-0.03	0.00	0.00
Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.03	-0.02
Cash from Financing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.06	0.01

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Change in Cash		0.71	-0.15	0.58	0.11	-0.60	0.02	0.74	0.60	0.06	0.01	-0.12
Closing Cash Balance		1.37	1.53	1.68	1.09	0.98	1.58	1.56	0.82	0.23	0.17	0.16

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		0.03	0.08	0.00	-0.26	0.11	0.19	0.23	0.05	0.04	0.39
Closing Cash Balance		1.53	1.50	1.41	1.41	1.67	1.56	1.37	1.14	1.09	1.05

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Free Cash Flow		1.09	1.73	1.41	0.54	0.47	0.17	0.26	0.24	0.43	0.72	0.74
Real Free Cash Flow		0.93	1.73	1.26	0.39	0.33	0.03	0.15	0.16	0.66	0.67	0.84

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		0.49	0.54	0.40	0.28	0.31	0.61	0.41	0.20	0.11	0.36
Real Free Cash Flow		0.61	0.54	0.37	0.24	0.31	0.61	0.38	0.16	0.06	0.33

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	37	33.1	1703.4
P/S	3.5	4.3	67.9
P/B	1.6	1.7	25.8
P/FCF	20.7	151.1	396.3
Market cap	$36.6	$40.9

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	16.6 %	12.5 %	0 %
Debt to Income	534.1 %	250.2 %	0 %
Debt to Free cash flow	299.2 %	6.6 %	0 %
Interest expense percentage	11.2 %	-2.2 %	38.7 %
Current ratio	2.1	1.7	0